Essex Bio-Technology is a bio-pharmaceutical company with its key products marketed in more than 10,000 hospitals since 1998. The company is focused on developing biologics and pharmaceuticals in the field of Dermatology, Oncology, Ophthalmology and Wound Healing. With 4 research sites globally, the company leverages on its in-house R&D expertise and platform in growth factors (i.e. FGF2) and antibodies to maintain a pipeline of research projects in various clinical stages, covering a wide range of fields and indications. www.essexbio.com